Ben-Porat LS - Search Results

1

Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy.

Ekenel M, Iwamoto FM, Ben-Porat LS, Panageas KS, Yahalom J, DeAngelis LM, Abrey LE. Ekenel M, et al. Among authors: ben porat ls. Cancer. 2008 Sep 1;113(5):1025-31. doi: 10.1002/cncr.23670. Cancer. 2008. PMID: 18618509 Free article.

2

Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis.

Panageas KS, Elkin EB, DeAngelis LM, Ben-Porat L, Abrey LE. Panageas KS, et al. Cancer. 2005 Dec 1;104(11):2466-72. doi: 10.1002/cncr.21481. Cancer. 2005. PMID: 16240449 Free article.

3

Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model.

Abrey LE, Ben-Porat L, Panageas KS, Yahalom J, Berkey B, Curran W, Schultz C, Leibel S, Nelson D, Mehta M, DeAngelis LM. Abrey LE, et al. J Clin Oncol. 2006 Dec 20;24(36):5711-5. doi: 10.1200/JCO.2006.08.2941. Epub 2006 Nov 20. J Clin Oncol. 2006. PMID: 17116938

4

Patterns of treatment in older adults with primary central nervous system lymphoma.

Panageas KS, Elkin EB, Ben-Porat L, Deangelis LM, Abrey LE. Panageas KS, et al. Cancer. 2007 Sep 15;110(6):1338-44. doi: 10.1002/cncr.22907. Cancer. 2007. PMID: 17647247 Free article.

5

Delayed neurotoxicity in primary central nervous system lymphoma.

Omuro AM, Ben-Porat LS, Panageas KS, Kim AK, Correa DD, Yahalom J, Deangelis LM, Abrey LE. Omuro AM, et al. Among authors: ben porat ls. Arch Neurol. 2005 Oct;62(10):1595-600. doi: 10.1001/archneur.62.10.1595. Arch Neurol. 2005. PMID: 16216945

6

Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma.

Ben-Porat L, Panageas KS, Hanlon C, Patel A, Halpern A, Houghton AN, Coit D. Ben-Porat L, et al. Cancer. 2006 Jan 1;106(1):163-71. doi: 10.1002/cncr.21594. Cancer. 2006. PMID: 16331596 Free article.

7

When you look matters: the effect of assessment schedule on progression-free survival.

Panageas KS, Ben-Porat L, Dickler MN, Chapman PB, Schrag D. Panageas KS, et al. J Natl Cancer Inst. 2007 Mar 21;99(6):428-32. doi: 10.1093/jnci/djk091. J Natl Cancer Inst. 2007. PMID: 17374832

8

Clinicopathological features of and risk factors for multiple primary melanomas.

Ferrone CR, Ben Porat L, Panageas KS, Berwick M, Halpern AC, Patel A, Coit DG. Ferrone CR, et al. JAMA. 2005 Oct 5;294(13):1647-54. doi: 10.1001/jama.294.13.1647. JAMA. 2005. PMID: 16204664

9

Particle embolization of recurrent hepatocellular carcinoma after hepatectomy.

Covey AM, Maluccio MA, Schubert J, BenPorat L, Brody LA, Sofocleous CT, Getrajdman GI, Fong Y, Brown KT. Covey AM, et al. Cancer. 2006 May 15;106(10):2181-9. doi: 10.1002/cncr.21883. Cancer. 2006. PMID: 16596622 Free article.

10

Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi--results from the NYU-LCMN registry.

Hale EK, Stein J, Ben-Porat L, Panageas KS, Eichenbaum MS, Marghoob AA, Osman I, Kopf AW, Polsky D. Hale EK, et al. Br J Dermatol. 2005 Mar;152(3):512-7. doi: 10.1111/j.1365-2133.2005.06316.x. Br J Dermatol. 2005. PMID: 15787820

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters